Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SCYNEXIS Appoints Animal Health VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

SCYNEXIS Appoints Animal Health VP

Doelling brings 20 years of R&D experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Vivian Doelling has been appointed vice president of Animal Health at SCYNEXIS, Inc. Dr. Doelling has more than 20 years of experience in the animal health field in the creation and management of biological R&D operations for therapeutic proteins and vaccines for human and animal use.
 
Previously, Dr. Doelling worked as a consultant for the biotechnology and animal health industries, focusing on product development, technology assessment, IP portfolio management, licensing, commercialization and strategic planning. Prior to this, she served as vice president of R&D for Embrex, Inc. and director of R&D after Pfizer Animal Health acquired Embrex.
 
“Vivian’s extensive background in animal health will play a key role in the development and growth of our animal health business, expanding our research beyond parasitology,” said Dr. Yves Ribeill, SCYNEXIS’ president and chief executive officer. “Her contributions to SCYNEXIS will be important as we continue to expand our offerings to our animal health partners and to identify new drug candidates, such as SCY-641 for the treatment of canine keratoconjunctivitis sicca.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics